Oculis Holding AG (OCS) Operating Income (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Operating Income of $266894.0 in Q1 2026, down 48.1% quarter-over-quarter from $514230.8 in Q4 2025, and down 15.8% on a YoY basis from $316991.4 in Q1 2025.
Oculis Holding AG (OCS) Operating Income (2022 - 2026) Analysis & Trends
Oculis Holding AG's Operating Income history runs 5 years deep, the most recent figure standing at $266894.0 for Q1 2026.
- In Q1 2026, Operating Income fell 15.8% year-over-year to $266894.0; the TTM figure through Mar 2026 stood at $1.1 million (down 99.97% YoY), while the FY2025 annual figure was $1.5 million, up 91.57% from the prior year.
- Operating Income was $266894.0 for Q1 2026 at Oculis Holding AG, down from $514230.8 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $3.4 billion in Q4 2024 to a low of $249.31 in Q3 2024.
- Historically, Operating Income has averaged $214.3 million across 5 years, with a median of $251765.9 in 2022.
- The sharpest annual moves came in 2024 and 2025: Operating Income surged 1641900.41% in 2024, then plunged 99.98% in 2025.
- A 5-year view of Operating Income shows it stood at $222136.7 in 2022, then slipped by 6.11% to $208560.6 in 2023, then surged by 1641900.41% to $3.4 billion in 2024, then slumped by 99.98% to $514230.8 in 2025, then tumbled by 48.1% to $266894.0 in 2026.
- The last three Operating Income figures came in at $266894.0 (Q1 2026), $514230.8 (Q4 2025), and $303.78 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 266,893.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266,893.98 |
| Dec 31, 2025 | 514,230.78 |
| Sep 30, 2025 | 303.78 |
| Jun 30, 2025 | 315,259.35 |
| Mar 31, 2025 | 316,991.40 |
| Dec 31, 2024 | 3.42 Bn |
| Sep 30, 2024 | 249.31 |
| Jun 30, 2024 | 270,919.40 |
| Mar 31, 2024 | 254,341.47 |
| Dec 31, 2023 | 208,560.58 |
| Sep 30, 2023 | 247,941.41 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | 247,586.23 |
| Dec 31, 2022 | 222,136.69 |
| Sep 30, 2022 | 209,162.24 |
| Jun 30, 2022 | 249,190.32 |